Ameriprise
CPIX icon

Ameriprise’s Cumberland Pharmaceuticals CPIX Stock Holding History

Ameriprise’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-23,892
Closed -$167K – 3680
2017
Q2 		$167K Buy
23,892
+80
+0.3% +$528 ﹤0.01% 3597
2017
Q1 		$165K Buy
+23,812
New +$144K ﹤0.01% 3501
2015
Q1 		– Sell
-10,366
Closed -$65K – 3903
2014
Q4 		$65K Buy
10,366
+1,300
+14% +$6.67K ﹤0.01% 3617
2014
Q3 		$45K Buy
+9,066
New +$43.9K ﹤0.01% 4066

Other funds holding CPIX

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ameriprise's CPIX Position: Q3 2017 in Review

Ameriprise sold out of Cumberland Pharmaceuticals (CPIX) in Q3 2017, closing a stake of 23,892 shares — an estimated $167K sold.

Ameriprise first reported a position in CPIX in Q3 2014 and held it in 4 quarters. The position peaked at $167K in Q2 2017. 33 funds tracked by Wall St. Rank hold CPIX as of Q3 2017.

  • Ameriprise reported no remaining Cumberland Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Ameriprise sold 23,892 Cumberland Pharmaceuticals shares in Q3 2017, an estimated $167K.
  • Ameriprise first reported a position in Cumberland Pharmaceuticals in Q3 2014 and held it in 4 quarters.
  • Ameriprise's Cumberland Pharmaceuticals position peaked at $167K in Q2 2017.
  • 33 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q3 2017.

Based on Ameriprise's 13F filing for Q3 2017, filed 7 Nov 2017.